1537 related items for PubMed ID: 9217756
1. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
[Abstract] [Full Text] [Related]
2. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G.
Kidney Int; 1998 May 28; 53(5):1209-16. PubMed ID: 9573535
[Abstract] [Full Text] [Related]
3. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy.
Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G.
Lancet; 1998 Oct 17; 352(9136):1252-6. PubMed ID: 9788454
[Abstract] [Full Text] [Related]
4. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G.
Lancet; 1999 Jul 31; 354(9176):359-64. PubMed ID: 10437863
[Abstract] [Full Text] [Related]
5. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G.
Kidney Int Suppl; 1997 Dec 31; 63():S54-7. PubMed ID: 9407422
[Abstract] [Full Text] [Related]
6. In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia.
Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore Q, Salvadori M, Remuzzi G.
J Am Soc Nephrol; 1999 May 31; 10(5):997-1006. PubMed ID: 10232685
[Abstract] [Full Text] [Related]
7. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).
Ruggenenti P, Perna A, Benini R, Remuzzi G.
J Am Soc Nephrol; 1998 Nov 31; 9(11):2096-101. PubMed ID: 9808096
[Abstract] [Full Text] [Related]
8. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.
Knoll GA, Fergusson D, Chassé M, Hebert P, Wells G, Tibbles LA, Treleaven D, Holland D, White C, Muirhead N, Cantarovich M, Paquet M, Kiberd B, Gourishankar S, Shapiro J, Prasad R, Cole E, Pilmore H, Cronin V, Hogan D, Ramsay T, Gill J.
Lancet Diabetes Endocrinol; 2016 Apr 31; 4(4):318-26. PubMed ID: 26608067
[Abstract] [Full Text] [Related]
9. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.
Am J Kidney Dis; 2000 Jun 31; 35(6):1155-65. PubMed ID: 10845831
[Abstract] [Full Text] [Related]
10. Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen).
Ruggenenti P, Perna A, Zoccali C, Gherardi G, Benini R, Testa A, Remuzzi G.
J Am Soc Nephrol; 2000 Jan 31; 11(1):88-96. PubMed ID: 10616844
[Abstract] [Full Text] [Related]
11. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
Erley CM, Berger ED, Heyne N, Klass M, Krämer D, Braun N, Wolf S, Risler T.
Dtsch Med Wochenschr; 1997 Aug 01; 122(31-32):953-8. PubMed ID: 9280714
[Abstract] [Full Text] [Related]
12. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.
Ruggenenti P, Perna A, Loriga G, Ganeva M, Ene-Iordache B, Turturro M, Lesti M, Perticucci E, Chakarski IN, Leonardis D, Garini G, Sessa A, Basile C, Alpa M, Scanziani R, Sorba G, Zoccali C, Remuzzi G, REIN-2 Study Group.
Lancet; 1997 Aug 01; 365(9463):939-46. PubMed ID: 15766995
[Abstract] [Full Text] [Related]
13. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
Am J Kidney Dis; 2009 Apr 01; 53(4):606-16. PubMed ID: 19216016
[Abstract] [Full Text] [Related]
14. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.
Ruggenenti P, Perna A, Remuzzi G, GISEN Group Investigators.
Kidney Int; 2003 Jun 01; 63(6):2254-61. PubMed ID: 12753315
[Abstract] [Full Text] [Related]
15. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
Clin Ther; 2008 Mar 01; 30(3):482-98. PubMed ID: 18405787
[Abstract] [Full Text] [Related]
16. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
Nephrol Dial Transplant; 2009 Dec 01; 24(12):3694-701. PubMed ID: 19628647
[Abstract] [Full Text] [Related]
17. Pretreatment blood pressure reliably predicts progression of chronic nephropathies. GISEN Group.
Ruggenenti P, Perna A, Lesti M, Pisoni R, Mosconi L, Arnoldi F, Ciocca I, Gaspari F, Remuzzi G.
Kidney Int; 2000 Nov 01; 58(5):2093-101. PubMed ID: 11044230
[Abstract] [Full Text] [Related]
18. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
Nephrol Dial Transplant; 2010 Jul 01; 25(7):2218-24. PubMed ID: 20106824
[Abstract] [Full Text] [Related]
19. Strict blood-pressure control and progression of renal failure in children.
ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.
N Engl J Med; 2009 Oct 22; 361(17):1639-50. PubMed ID: 19846849
[Abstract] [Full Text] [Related]
20. Add-on angiotensin receptor blockade with maximized ACE inhibition.
Agarwal R.
Kidney Int; 2001 Jun 22; 59(6):2282-9. PubMed ID: 11380832
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
